Clinical Trial Update: Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating therapeutic drug monitoring of tildrakizumab in psoriasis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Psoriasis Vulgaris | Phase 4 | Status: UNKNOWN